Egyptian pharmaceutical company Utopia Pharmaceuticals has announced plans to establish a drug manufacturing facility in Abia State, targeting the Nigerian and broader West African pharmaceutical market. Founder Kamel Muhamed disclosed the investment proposal during a meeting with Governor Alex Otti in Isiala Ngwa South on Wednesday.
The proposed manufacturing plant would position Nigeria as a regional hub for advanced pharmaceutical technology, according to Muhamed. Utopia Pharmaceuticals currently operates under an existing Memorandum of Understanding between Egypt and Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), which facilitates pharmaceutical cooperation between both nations.
Governor Otti responded positively to the investment proposal, directing the Egyptian investors toward the Ukwa axis of the state. The governor cited the area’s abundant natural gas reserves, reliable electricity supply from Geometric Power, and extensive land availability as key advantages for industrial development.
The investment comes as Nigeria continues to pursue pharmaceutical self-sufficiency and regional export capacity. The West African pharmaceutical market has attracted increasing interest from international manufacturers seeking to establish production bases within the Economic Community of West African States (ECOWAS) region.
Brandspur Banking News Desk reports that the Abia State government has been actively courting foreign direct investment across multiple sectors, with particular emphasis on industries that can leverage the state’s energy infrastructure and strategic location.
The Ukwa axis, which Otti specifically recommended, offers significant natural gas deposits that could support pharmaceutical manufacturing operations requiring consistent energy supply. Geometric Power’s presence in the area provides additional assurance for industrial-scale production needs.
Utopia Pharmaceuticals’ interest in the Nigerian market aligns with broader continental healthcare initiatives under the African Continental Free Trade Area, which seeks to boost intra-African pharmaceutical trade and reduce dependency on imports from outside the continent.
The Egyptian company has not disclosed specific investment figures or projected timelines for the proposed Abia plant. However, the meeting signals concrete progress in Nigeria-Egypt bilateral economic cooperation in the pharmaceutical sector.
Governor Otti’s administration has prioritised industrial revitalisation since assuming office, with several investment delegations visiting the state in recent months. The pharmaceutical plant proposal represents one of the larger manufacturing investments under consideration for the state’s industrial development agenda.
NAFDAC’s existing cooperation framework with Egypt provides regulatory foundation for Utopia Pharmaceuticals’ Nigerian operations, potentially streamlining the approval process for the proposed manufacturing facility.
The plant would serve both Nigeria’s domestic pharmaceutical needs and export markets across West Africa, leveraging Nigeria’s position as the region’s largest economy and most populous nation. Nigerian pharmaceutical imports have traditionally dominated the West African market, making local manufacturing a strategic priority for economic development.
